Loading company…
PathNova uses machine learning to support detection of nasopharyngeal cancer and autoimmune disease.
PathNova develops an AI framework to scale detection of nasopharyngeal cancer and autoimmune disease. Its system automates immunofluorescence analysis using pattern recognition to measure disease indicators. Founded in 2017 as a spinout from Temasek Life Sciences Laboratory, the company is based in Singapore.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in